M D Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT04482647
This phase I trial investigates breathing techniques and meditation for health care workers during COVID-19 pandemic. Breathing techniques and medication may help manage stress and improve lung health. The goal of this trial is to learn if breathing techniques and meditation may help to reduce stress and improve lung health in health care workers during the COVID-19 pandemic.
This study is active but is not currently recruiting participants.
Notify MeUp to 70 year
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
PRIMARY OBJECTIVE:
I. To demonstrate the feasibility of a short pranayama or breathing techniques and meditation during Covid-19 pandemic.
SECONDARY OBJECTIVES:
I. To determine the adherence to the practice assessed as at least 50% of participants implement the intervention for 3 or more times in a week by the end of week 1/day 7 (+ 3 days).
II. To determine the change in resilience, perceived stress and psychological impact from day 0 today 28 as measured by the Brief Resilient Coping Scale (BRCS), Perceived Stress Scale (PSS4), and COVID-19 Stress among health care workers questionnaire.
III. To determine the changes in breath holding time measured weekly for 4 weeks.
IV. To determine the differences in breath holding time between those who are adherent and those who are not adherent to the practice.
OUTLINE:
Patients view an instructional video on breathing techniques and meditation. Patients then perform breathing techniques over 3 minutes and meditation over 2 minutes twice daily (BID) for 28 days.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
View instructional video
Perform meditation
Other names: Meditation
Ancillary studies
Other names: Quality of Life Assessment
Ancillary studies
Perform breathing techniques
Other names: Yoga Therapy
Time frame: Within 2 months
To demonstrate the feasibility of a short pranayama or breathing techniques and meditation during Covid-19 pandemic. Feasibility will be defined as recruitment of 50 participants to the study within 2 months.
Time frame: Week 1 and Week 4
Defined as more than 50% of participants perceive the intervention as useful. Meditation perception questions were asked such as usefulness, feeling at peace, hopeful, or relaxed, and responses were recorded as strongly agree, agree, neutral, disagree, and strongly disagree at weeks 1 and 4.
Time frame: 4 weeks
Measured by the Brief Resilient Coping Scale among health care workers questionnaire.
Time frame: 4 weeks
Measured by the Perceived Stress Scale and COVID-19 Stress among health care workers questionnaire.
Time frame: 4 weeks
Will determine the differences in breath holding time between those who are adherent and those who are not adherent to the practice.
Time frame: 4 weeks
Will determine the adherence to the practice assessed as at least 50% of participants implement the intervention for 3 or more times in a week by the end of week 1/day 7 (+ 3 days).
M.D. Anderson Cancer Center
Other
Breathing Techniques and Meditation for Health Care Workers During COVID-19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04387656
COVID-19, COVID-19 Infection
Birmingham, Alabama, United States
View Trial DetailsNCT05228275
COVID-19, COVID-19 Infection
Birmingham, Alabama, United States
View Trial DetailsNCT04500600
COVID-19, COVID-19 Infection
Houston, Texas, United States
View Trial DetailsNCT04565665
COVID-19, COVID-19 Infection
Houston, Texas, United States
View Trial Details